Tarceva Gets Thumbs Down For NSCLC Maintenance As Cmte. Seeks Better Subgroup Analyses

ODAC expresses concern over OSI's use of "a single study with some design flaws showing very modest benefits."

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet